No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...

VALANX Biotech (VALANX), a biotech company developing novel antibody-drug-conjugate (ADC) assets enabled by its GoldenSite™ site-specific protein conjugation technology, today announced the formation ...

To address this, Thermo Fisher Scientific now offers Accelerator Drug Development: a suite of integrated services combining CDMO and CRO capabilities to streamline the drug development journey, from ...

Last month marked a major turning point as Google launched Gemini 3 [1], proving that new AI models can now outperform humans on critical tasks. At the same time, global regulators accelerated the ...

US cancer center partners with Syantra Inc. for further testing of Onco-ID Breast, a whole blood mRNA test for hyper-early cancer detection CALGARY, AB, Dec. 9, 2025 /CNW/ – Syantra, Inc.

The mRNA synthesis and manufacturing market's potential lies in the increasing demand for mRNA therapeutics and vaccines, driven by COVID-19 successes. Opportunities include mRNA custom synthesis and ...

Specifically, the team tested whether mRNA technology could be used to protect against the damage inflicted by the venom of ...

Stocks closed higher Tuesday, a day after the three major equities indexes ended their runs of five consecutive winning sessions.

Developers of mRNA therapeutics face an increasingly complex landscape: rising expectations for potency and durability, ...

Major stock indexes pulled back as the final trading month of the year began, with shares of big tech and cryptocurrency-tied firms falling amid risk-off sentiment.

Australia's sovereign vaccine manufacturing capability has been given a major boost with the opening of the Southern Hemisphere's first cell-based ...